Supplementary Figure 1
Overexpression of mutant TBP in different brain regions. a Representative immunofluorescence images showing the transduction of AAV-TBP in the cerebellum, striatum and prefrontal cortex. Scale bar = 20 μm. b Immunofluorescence staining (Scale bar = 100 μm) and Nissl staining (Scale bar = 10 μm) indicated that TBP-105Q dramatically decreased the number of neuronal cells in the cerebellum. c The number of Nisslstained cells per image is presented as mean ± SEM. One-way ANNOVA followed with Tukey's multiple comparisons test was performed, F = 14.36, *** P < 0.0005, **** P < 0.0001. Data are represented as mean ± SEM. n = 3 mice per group, three images were used to count from each mouse. Source data are provided as a Source Data file.
Supplementary Figure 2
Overexpression of mutant TBP causes increased reactive astrogliosis in different brain regions. a-c Immunofluorescence staining showing increased reactive astrogliosis in a polyQ length dependent manner in the cerebellum (a), striatum (b) and prefrontal cortex (c). Scale bar = 50 μm. d Quantification of GFAP staining intensity. Data are presented as fold change compared to TBP-13Q (dashed line) in the cerebellum, striatum, and prefrontal cortex (mean ± SEM). One-way ANNOVA followed with Tukey's multiple comparisons test was performed, cerebellum, F = 78.13; striatum, F = 10.58; prefrontal cortex, F = 152; * P < 0.05, *** P < 0.0005, **** P < 0.0001. Data are represented as mean ± SEM. n = 3 mice per group, three images were used to count from each mouse. Source data are provided as a Source Data file.
Supplementary figure 3 (continued)
Supplementary Figure 3 Gene enrichment analyses of differentiated expressed genes in the cerebellum, striatum and prefrontal cortex in SCA17 knock-in mice. a-f Top 10 enriched pathways of differentiated expressed genes in the cerebellum (a-b), striatum (c-d), and prefrontal cortex (e-f). g Common 28 up-regulated genes in three brain regions was enriched in immune related pathways. h-m Top 10 enriched GO process of differentiated expressed genes in the cerebellum (h-i), striatum (j-k), and prefrontal cortex (l-m). Source data are provided as a Source Data file.
Supplementary Figure 4
Three isoforms of mouse Inpp5a gene. a Schematic map of three known isoforms of the mouse Inpp5a gene. The coding sequences of isoform A, B and C are 1239, 1269 and 1263 bp respectively. Sequence alignment reveals that isoform A and isoform B differ in their C terminus; isoform C has a distinct promoter and exon1 sequence. The location of the GC box (red rectangle), gRNA targeting sites (red triangle), antibody epitope (curly bracket) and PCR primers (arrow) are indicated. b Polymerase chain reaction (PCR) analysis using isoform-specific primers showed different expression levels of two Inpp5a isoforms in the cerebellum (CB) and prefrontal cortex (PFC). Common primers, Forward 1 (1F): 5'-GCA TCC TCA TGT CCC TGT CT-3' and reverse 1 (1R): 5'-TTA GGA GGA TGA GTT GGA TA-3', amplified 272 bp PCR products for isoform A or C and 221 bp for isoform B. Isoform C specific primers, 2F: 5'-GAA AGA CAT GGC CTG GAG AG-3' and 2R: 5'-GGA GGC CTC GTA GTT TTT CC-3', amplified a 146 bp PCR product. Since there were no 221 bp PCR products, isoform B may not be expressed or may be expressed at an undetectable level in the cerebellum and prefrontal cortex. A positive control (upper band: 300 bp, lower band: 250 bp) demonstrated that the resolution of 2% agarose gel is sufficient to distinguish small bands. c Quantification of PCR products. GAPDH is used as the internal control. Densitometric ratios of Inpp5a to GAPDH were normalized to CB, and were analyzed with Student's t test. t = 2.519, # P = 0.0655, t = 8.059, ** P = 0.0013, n = 3 mice per group. d RNA sequencing identified that Inpp5a, but not other Inpp5 paralogs, was significantly downregulated in the cerebellum of SCA17 knock-in (KI) mice, compared to wild type (WT) mice. The data were analyzed with Student's t test, t = 8.474, ** P = 0.0011. n = 3 mice per group. Data are represented as mean ± SEM. Source data are provided as a Source Data file.
Supplementary Figure 5
Mutant TBP affects SP1 transcriptional activity. a Western blotting shows the expression of SP1 with TBP-13Q, -44Q, -68Q, or -105Q in transfected HEK293 cells. b Luciferase activity analysis of HEK293 cells transfected with SP1 and TBP-13Q, -44Q, -68Q or -105Q, suggesting that mutant TBP affects SP1's transcriptional activity on Inpp5a independent of polyQ repeat length. Luminescence intensity was analyzed with One-way ANNOVA followed with Tukey's multiple comparisons test. F = 22.87, ** P < 0.005, *** P < 0.0005, **** P < 0.0001. Data are represented as mean ± SEM. Source data and full blots are provided as a Source Data file. Figure 6 Verification of targeting the mouse Inpp5a by its gRNA and CRISPR/Cas9. a T7 Endonuclease I (T7E1) assay using genomic DNA from Neuro2a cells transfected with Cas9 plus control gRNA or Inpp5a gRNA verified the targeting of the mouse Inpp5a gene by its gRNA. b Representative immunofluorescence images of AAV-control gRNA-or AAV-Inpp5a gRNA-injected cerebellum in Cas9 transgenic mice without mutant TBP. RFP (red) represents viral transduction and gRNA expression. Arrow indicates AAV-Inpp5a gRNA-injected region that shows loss of calbindin-labeled Purkinje cells (green) as compared with the region without AAV transduction or with AAV-control gRNA injection.
Supplementary
Scale bar = 100 μm. c Representative Nissl staining images (left panel) of AAV-GFP or AAV-Inpp5a injected cerebellum in SCA17 mice. Scale bar = 50 μm. Quantification of Purkinje cells (right panel) was analyzed with Student's t test, t = 3.581, ** P = 0.0025. Data are represented as mean ± SEM. n = 3 mice per group, three images were used to count from each mouse. Source data are provided as a Source Data file. 

